Xenon Pharmaceuticals Inc.

NASDAQ:XENE

Biotechnology

Healthcare
$37.56 -0.55%

-$0.29 today

Market cap
$3.69B
Beta
0.63
P/E (TTM)
-12.1
EPS (TTM)
-$4.39
52W Low $30.00High $63.95

Volume 1.28M

Average 1.16M

Balance Sheet

Inspect the capital base behind the business.

Assets

$981.67M

FY 2025 · Annual

+23.0% YoY

Liabilities

$399.91M

FY 2025 · Annual

+824.9% YoY

Equity

$581.76M

FY 2025 · Annual

-22.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents175.69M57.24M148.64M142.71M199.16M
Short-term Investments376.09M534.85M489.44M484.19M349.72M
Net Receivables2.77M986K874K1.47M1.37M
Inventory00000
Other Current Assets07.23M6.01M6.89M10.39M
Total Current Assets559.02M600.3M644.96M635.26M560.65M
Property, Plant & Equipment (Net)12.52M16.91M18.85M18.22M15.35M
Goodwill00000
Intangible Assets00000
Long-term Investments0128.68M292.79M127.5M37.15M
Tax Assets465K509K802K9.67M361.37M
Other Non-current Assets07.75M7.4M7.5M7.15M
Total Non-current Assets12.99M153.85M319.84M162.88M421.02M
Total Assets572.01M754.15M964.8M798.14M981.67M
Account Payables3.82M8.49M8.6M5.07M3.89M
Short-term Debt00001.53M
Tax Payables0005.69M0
Deferred Revenue00000
Other Current Liabilities5.94M5.82M347K9.93M21.6M
Total Current Liabilities14.32M22.7M27.27M35.59M41.79M
Long-term Debt00000
Deferred Tax Liabilities0000348.51M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00003.2M
Total Non-current Liabilities7.65M9.95M9.6M7.65M358.12M
Total Liabilities21.97M32.65M36.88M43.24M399.91M
Common Stock783.17M1.07B1.44B1.46B1.6B
Retained Earnings(357.37M)(482.75M)(665.14M)(899.47M)(1.25B)
Accumulated OCI(990K)(3M)(77K)(1.61M)335K
Other Stockholders Equity00000
Minority Interest00000
Total Equity550.03M721.5M927.92M754.9M581.76M
Total Debt8.26M10.44M10.9M9.02M7.94M
Net Debt(167.43M)(46.81M)(137.74M)(133.7M)(191.22M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$82.6M
Short-term Investments$868.2M
Receivables$1.2M
Other Current$8.1M
Total Current Assets$960.1M
PP&E (Net)$12.5M
Long-term Investments$202.7M
Tax Assets$15.5M
Other Non-current$9.2M
Total Non-current Assets$239.8M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $868.2M, about 72.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
S-8S-8 filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13GSC 13G filingNov 6, 2026

How much cash does XENE have?

Xenon Pharmaceuticals Inc. (XENE) reported $199.16M in cash and equivalents in fiscal 2025.

How much debt does XENE carry?

Xenon Pharmaceuticals Inc. (XENE) reported $7.94M of total debt, with net debt of -$191.22M.